1. Home
  2. CERS vs SNFCA Comparison

CERS vs SNFCA Comparison

Compare CERS & SNFCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • SNFCA
  • Stock Information
  • Founded
  • CERS 1991
  • SNFCA 1965
  • Country
  • CERS United States
  • SNFCA United States
  • Employees
  • CERS N/A
  • SNFCA N/A
  • Industry
  • CERS EDP Services
  • SNFCA Finance: Consumer Services
  • Sector
  • CERS Technology
  • SNFCA Finance
  • Exchange
  • CERS Nasdaq
  • SNFCA Nasdaq
  • Market Cap
  • CERS 271.4M
  • SNFCA 246.9M
  • IPO Year
  • CERS 1997
  • SNFCA N/A
  • Fundamental
  • Price
  • CERS $1.34
  • SNFCA $9.77
  • Analyst Decision
  • CERS Strong Buy
  • SNFCA
  • Analyst Count
  • CERS 2
  • SNFCA 0
  • Target Price
  • CERS $3.50
  • SNFCA N/A
  • AVG Volume (30 Days)
  • CERS 1.4M
  • SNFCA 43.3K
  • Earning Date
  • CERS 07-31-2025
  • SNFCA 08-13-2025
  • Dividend Yield
  • CERS N/A
  • SNFCA N/A
  • EPS Growth
  • CERS N/A
  • SNFCA 11.71
  • EPS
  • CERS N/A
  • SNFCA 0.98
  • Revenue
  • CERS $185,144,000.00
  • SNFCA $336,074,193.00
  • Revenue This Year
  • CERS $24.95
  • SNFCA N/A
  • Revenue Next Year
  • CERS $8.48
  • SNFCA N/A
  • P/E Ratio
  • CERS N/A
  • SNFCA $10.02
  • Revenue Growth
  • CERS 13.06
  • SNFCA 4.96
  • 52 Week Low
  • CERS $1.12
  • SNFCA $6.95
  • 52 Week High
  • CERS $2.54
  • SNFCA $13.59
  • Technical
  • Relative Strength Index (RSI)
  • CERS 48.75
  • SNFCA 47.55
  • Support Level
  • CERS $1.29
  • SNFCA $9.35
  • Resistance Level
  • CERS $1.41
  • SNFCA $10.13
  • Average True Range (ATR)
  • CERS 0.10
  • SNFCA 0.32
  • MACD
  • CERS -0.01
  • SNFCA -0.01
  • Stochastic Oscillator
  • CERS 27.27
  • SNFCA 57.30

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About SNFCA Security National Financial Corporation

Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.

Share on Social Networks: